Literature DB >> 19387474

Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?

Thilo Krueger1, Ralf Westenfeld, Markus Ketteler, Leon J Schurgers, Jürgen Floege.   

Abstract

The purpose of this review is to summarize currently available evidence implicating vitamin K in the pathogenesis of vascular calcification (VC), in particular arterial medial calcification. In doing so, we try to provide a rationale for an interventional clinical study testing whether vitamin K supplementation can retard VC or even affect cardiovascular mortality in chronic kidney disease patients. Additionally, we wish to give an overview of the current literature indicating potential adverse effects of long-term vitamin K antagonists in this population.

Entities:  

Mesh：

Year:  2009        PMID： 19387474     DOI： 10.1038/ki.2009.126

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  28 in total

1.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

2.  Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases.

Authors:  Markus Ketteler; Patrick H Biggar
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

4.  Chronic kidney disease: How effective and safe are antiplatelet agents in CKD?

Authors:  Jürgen Floege; Georg Schlieper
Journal:  Nat Rev Nephrol       Date:  2013-04-30       Impact factor: 28.314

Review 5.  Mechanisms and treatment of extraosseous calcification in chronic kidney disease.

Authors:  Markus Ketteler; Hansjörg Rothe; Thilo Krüger; Patrick H Biggar; Georg Schlieper
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 6.  Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship.

Authors:  M Fusaro; G Crepaldi; S Maggi; F Galli; A D'Angelo; L Calò; S Giannini; D Miozzo; M Gallieni
Journal:  J Endocrinol Invest       Date:  2010-11-16       Impact factor: 4.256

Review 7.  Growth arrest-specific gene 6 (gas6) and vascular hemostasis.

Authors:  Sandrine Laurance; Catherine A Lemarié; Mark D Blostein
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

8.  Vitamins K and D status in stages 3-5 chronic kidney disease.

Authors:  Rachel M Holden; A Ross Morton; Jocelyn S Garland; Andrey Pavlov; Andrew G Day; Sarah L Booth
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

9.  Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.

Authors:  Piergiorgio Bolasco
Journal:  Int J Nephrol       Date:  2011-06-09

10.  Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease.

Authors:  Christiaan Lucas Meuwese; Hannes Olauson; Abdul Rashid Qureshi; Jonaz Ripsweden; Peter Barany; Cees Vermeer; Nadja Drummen; Peter Stenvinkel
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.